Patent Application
20170281865
A harvesting and reinjection procedure of viable soft tissue typically consists of several different chronological steps [U.S. Pat. No. 8,968,272 Khouri et. al]. including:
1. Infiltration of tumescent fluid
2. Aspiration of viable soft tissue using liposuction
3. Processing aspirated tissue to remove debris, oil, blood, infranate, and saline
4. Reinjecting viable tissue using a cannula
Adipose tissue consists of many small adipocytes held together by fibers in larger agglomerates [U.S. Pat. No. 5,052,999 Klein]. During a liposuction procedure, a harvesting cannula removes these agglomerates, together with other cells and fluids, including saline solution, blood and oil. The harvesting cannula is comprised of a long, hollow metal tube with one or more openings at or near the distal end, and fitted onto a hand piece [U.S. Pat. No. 5,052,999 Klein, Liposuction, Principles and Practice]. The cannula is inserted into a region of the body through a small incision in the skin. With the cannula attached to a vacuum source, adipose tissue is pulled through the openings and into the inner lumen of the cannula [U.S. Pat. No. 5,052,999 Klein, Liposuction, Principles and Practice]. The adipose tissue is then collected in a container [U.S. Pat. No. 8,172,832 Fat harvesting container]
During the previous steps 2 thru 4, viable tissues have been subject to several damaging forces that could compromise their viability[ ]. These forces include:
1. Excessive negative or positive pressures
2. Shearing forces 3. Blunt forces
Liposuction procedures have been performed for decades, and more recently the adipose fat tissue removed has been reinjected into other body parts with moderate success [U.S. Pat. No. 8,968,272 Khouri et. al]. However, very little care was taken to assure tissue viability during the procedure. The focus was to minimize procedure time while maintaining patient safety. Recently, reinjection of harvested tissue has become more popular. This reinjection of adipose tissue has not been an exact science regarding how each of the forces and methods of transfer affect the viability of the live tissue. Individual surgeons base their values and recommendations on experience in doing large numbers of procedures. Patterns emerge when using certain techniques and devices repeatedly, which lead to these values and recommendations. Pressures, flow rates and distribution patterns of reinjected adipose tissue have become some of the important physical characteristics that affect live tissue viability [U.S. Pat. No. 8,968,272 Khouri et. al].
During the aspiration procedure, 18 inHg of negative pressure is considered by some a recommended maximum limit to assure cell viability. Ideally, the negative pressure should only reach workable levels [Wells Johnson Pending Patent ] or that which is only necessary to achieve fat removal; which can vary from patient to patient and will vary from 18 inHg. It has been found that even while pressures required to harvest adipose tissue vary from patient to patient, they can even vary from location to location in the body of the same patient. This means that the surgeon will select the vacuum level(s) required to achieve optimum results from a wide range of vacuum pressures. True fluid management will allow control over a broad range of pressures, match and control those optimum pressures selected during aspiration [U.S. Pat. No. 8,968,272 Khouri et. al and U.S. Pat. No. 8,936,593].
Currently syringes are used for reinjecting the harvested and processed adipose tissue. Once the blood and saline have been removed from the large syringe or container, the processed adipose tissue is typically transferred into a smaller syringe. A reinjection cannula is attached to this smaller syringe and the tissue is reinjected back into the patient using positive pressure. The reinjection cannula has a similar design as the harvesting cannula, consisting of a hollow metal tube with one or more openings at or near the distal end, and fitted onto a hand piece. In the current art, positive pressures are not controlled using this method [Fat harvesting container], and the agglomerates of adipose tissue may experience very high positive pressure as they transition from the large syringe inner diameter to the very small inner diameter of the reinjection cannula. Another disadvantage is that this method requires the use of multiple syringes, with dedicated personnel to fill and handle the syringes.
In the case of a clog, even greater, and most times excessive, positive pressure is applied to clear the clog. A clog occurs when an oversized agglomerate occludes the pathway for adipose tissue. Clogs can be hard to locate, and both time consuming and labor intensive to clear. Currently, clogs are cleared by drastically increasing the positive and/or negative pressures. Positive pressures can reach 40 psi or more using a syringe [U.S. Pat. Nos. 5,002,538, 8,771,592]. This is well in excess of the range of pressures used during aspiration. While the reinjection procedure is done using a syringe, in some cases a peristaltic pump may be used. Current peristaltic pumps have only settings for in reinjection can easily achieve 25 psi or more of pressure which is also well in excess of the range of pressures used during aspiration.
During an aspiration procedure, controlling flow rates and pressures is a very common and standard practice, however very little attention is given to the reinjection side of the procedure in regards to flow rates and pressures. A vacuum level can never exceed minus 1 atm, so regardless of how fast the flow rate is this level will never be exceeded. Flow rates and pressures are more loosely tied in an aspiration procedure, since a custom vacuum level can be set using a regulator or relief valve near the pumps. This ensures that the vacuum level never exceeds that amount anywhere upstream of the regulator, regardless of how high the flow rate of the vacuum pumps. With reinjection, positive pressures are used to move the adipose tissue, and extreme pressures of well over 1 atm can be easily achieved. This requires closer control of both flow rates and pressures when reinjecting adipose tissue. The ideal goal will be to maximize flow rates, while at the same time controlling the positive pressure levels in the tubing, the reinjection cannula and the recipient site.
The invention is a process and a system that is all inclusive of a system that includes all parts labeled in the five figures and the process that utilizes any combination of the current features not found in the prior art. The novelty of this process includes the simultaneous control of the reinjection pressure and flow rates while matching the holes' sizes in the reinjection cannula with those of the harvesting during the same process or procedure of removing the fat cells and fluid.
While flow rates and pressures are important, the distribution and pattern of the flow plays a role in tissue viability. It has been recommended that agglomerates of adipose tissue not be too large, and to be spread out. This is because after the agglomerate has been reinjected to the recipient site of a patient, each adipocyte must receive a blood supply to survive. Without a blood supply, the adipocyte dies and is recycled by the body. With an agglomerate that is too large, or with too many agglomerates stuffed into one area, blood flow can be restored only to the adipocytes on the outer surface, while the adipocytes located deep inside the agglomerates do not receive blood. This causes a collapse of the agglomerate as the adipocytes die, and results in unpredictable long term results of the reinjection procedure.
The flow distribution pattern is traditionally done by pressing the syringe plunger using ones thumb. By moving in a constant motion, pushing and releasing the plunger in a pattern creates boluses. Another method is to apply constant pressure to the plunger and make small stop and go motions with the hand as the cannula is moved back and forth through the recipient site. Both of these methods can create smaller, segmented boluses inside the recipient site. An improvement of this style is to automate the creation of these boluses using the reinjection pump. No such feature is available with current peristaltic pumps, so the pattern cannot be duplicated. This automation of pulses would allow the surgeon to move the reinjection cannula steadily in a continuous motion, while the pump creates the pulses and boluses.
What is needed is a system to allow fluid management that is precise and easy to use which allows control over pressure levels, flow rates and flow distribution patterns during the reinjection procedure.
The preferred embodiment of the present invention is the system and process of reinjecting adipose tissue with fluid management controls. The reinjection process of the present invention comprises the following:
A preferred embodiment of the invention and process is as follows. The reinjection pump uses a peristaltic pump head, along with flexible tubing to move adipose tissue from the container, through the reinjection cannula and into the recipient site. One end of the flexible tubing is attached to the container. The tubing is run through the peristaltic pump head and an external sensor. When the pump is activated, it draws the material from the container using a vacuum force. Once the material passes through the pump head it is moved using positive pressure. The external sensor measures this internal positive pressure and provides feedback to the reinjection pump. The feedback allows the user to control an upper limit for this pressure, as well as pumped through the tapered entrance of the reinjection cannula and into the recipient site. If at any time the pressure exceeds the limit set by the user, the pump automatically stops and reverses to zero pressure. A footswitch is installed to give remote access to the on/off function of the pump.
When all the above parts of the preferred embodiment of the present invention are working together, the following features and benefits may be achieved:
The preferred embodiment of the present invention allows controls of pressure, flow speeds and flow patterns. Using a mechanical pump to reinject adipose tissue can be dangerous to the patient and to the adipocytes without controls over important parameters. Pressure is defined as the positive pressure developed in the flexible tubing after it has been pushed through the pump. The present invention measures the pressure using an external pressure sensor that clamps onto the outside of the flexible tubing. The preferred embodiment uses a load cell that measures force. The internal pressure expands/contracts the flexible tubing and exerts a force on the load cell that is proportional to the pressure. Flow speeds are adjusted by simply changing the speed with which the pump moves, whether rotational or linear. Flow distribution pattern settings are controlled by indexing the pump into small increments of stop and go motion. The frequency of this stop-and-go motion can be adjusted up or down and relates to the number of pulses per minute. The size of the pulse is adjusted by increasing or decreasing the speed of the rotation during each stop and go motion.
The preferred embodiment of monitoring the positive internal pressure of the tubing is described above, however measuring this internal positive pressure is not limited to that only. A sensor may be used to detect internal pressure from outside or inside the flexible tubing, which may be a transducer of any of the following types: piezoresistive strain gauge, capacitive, electromagnetic, piezoelectric, optical, from the transducer is to allow a closed loop monitoring of pressure to the reinjection pump, however the signal from the transducer may also be used as an open loop monitoring. An example would be that the signal from the transducer would be used to display a live readout of the pressure to the user. Another way to monitor pressure in the tubing is to monitor the motor itself. Increasing pressure may be translated as an increased load on the motor. This increased load may be monitored using a sensor for current, voltage, torque, force or any combination of two or more of these.
The present invention consists of a process and system of parts that together form a reinjection system and process for transferring adipose tissue and providing fluid management. The process and system of parts consists of a canister or container (1), reinjection pump (3), flexible tubing (2), a reinjection cannula (4) and a recipient site (5). It includes the specific novel features of this process not previously utilized in the prior art.
The setting for revolutions per minute is referred hereafter as the speed of the motor. The speed is also the revolutions per minute of the peristaltic pump head (9), since the motor shaft is directly coupled to the peristaltic pump head (9) shaft. Control of the speed is very important for reinjecting adipose tissue because the tissue can only flow so fast through the flexible tubing (2) and the reinjection cannula (4). The main flow restriction is the small inner lumen of the reinjection cannula (4). If the speed setting is too high, the adipose tissue will be pushed into the flexible tubing (2) faster than it is leaving. This will increase the pressure and may trigger the upper pressure limit of the reinjection pump (3). The reinjection cannula (4) has a machined taper (23) where the flexible tubing (2) connects to the reinjection cannula (4). This taper (23) acts as a down to the smaller inner diameter of the reinjection cannula (4).
The pressure limit of the reinjection pump is the maximum internal pressure (21) desired inside the flexible tubing (2). If the external pressure sensor (10) detects a pressure that exceeds the limit, it will immediately stop the motor, which begin pumping in reverse until the internal pressure (21) is reduced to near zero. The zero pressure is simply the internal pressure (21) when the sensor is zeroed before the procedure, and is typically atmospheric pressure. The user will have to release and press the footswitch again to resume normal forward pumping. The pressure limit feature using the external pressure sensor (10) automatically limits the pressure, and allows the surgeon to focus on more important matters, such as placement of reinjected tissue.
The ability to set a number of pulses per minute allows the user to create a pattern to the flow. Pulses are created by rotating the peristaltic pump head (9) forward quickly a small amount, stopping, and moving forward again quickly a small amount. When set correctly, the pulses propagate through the fluid in the flexible tubing (2), with the effect that the fluid exits the end of the reinjection cannula (4) in small boluses, or droplets, automatically. This can eliminate the back and forth motion of the hand during reinjection by automatically placing a segmented array of boluses with a straight movement of the cannula end. Controlling the bolus size is an important factor in maintaining adipose tissue viability by spacing out the agglomerates and maximizing vascularization.
The present invention includes a focus on maintaining a constant, smooth, continuous lumen throughout the entire system. This means that after the adipose tissue leaves the container (1), the inner diameter of the flexible tubing (2) and all connections are to be maintained through all processes, until it reaches the reinjection cannula (4). This helps the adipose tissue move gently along the flexible tubing (2) path by removing choke points and small orifices to squeeze through, such as luer lock fittings and one way valves. The system contains only one component that has an active role in contacting the adipose tissue, the flexible tubing (2). This flexible tubing (2) comes in disposable, pre-sterilized packs to allow a sterile environment for the adipose tissue.
This application is a non-provisional application being filed under 37 CFR 1.53(b) and 35 USC 111 as a divisional of the presently pending U.S. patent(s) all of which are hereby incorporated by reference. Application No.—62/179,885 Filing Date—May 22, 2015 Title—Process and System for Fluid Management during Reinjection of Adipose Tissue .
| Number | Date | Country | |
|---|---|---|---|
| 62179885 | May 2015 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15132947 | Apr 2016 | US |
| Child | 15160818 | US |
